The American Journal of Cardiology · 2004 · 164 citations · 25 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyCardiovascular DiseaseCholesterol MetabolismDyslipidemia ManagementDyslipidemia PharmacotherapyLipid DisordersLipid-lowering TherapyLow-density Lipoprotein Cholesterol LoweringPlasma Cholesterol Levels
25
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
A. Leone, S. Moncada, Patrick Vallance et al. · The Lancet · 1992 · 2.1K citations
Medicine, Nephrology, Pharmacology +11
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Ulrich Laufs, Vito La Fata, Jorge Plutzky et al. · Circulation · 1998 · 1.8K citations · Full text
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text
Medicine, Cardiology, Pharmacology +12
Endogenous Nitric Oxide Synthase Inhibitor
Hiroshi Miyazaki, Hidehiro Matsuoka, John P. Cooke et al. · Circulation · 1999 · 764 citations · Full text
Medicine, Cardiology, Pharmacology +15